[{"address1": "4870 Sadler Road", "address2": "Suite 300", "city": "Glen Allen", "state": "VA", "zip": "23060", "country": "United States", "phone": "804 487 8196", "website": "https://www.adial.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 64, "title": "CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 561331, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 61, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 342828, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vinay  Shah A.C.A., M.B.A.", "age": 62, "title": "CFO & Treasurer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andrew  Taubman", "title": "Vice President of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brigitte  Robertson M.D.", "age": 61, "title": "Acting Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Abel  Svitavsky CPA", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.22, "open": 0.234, "dayLow": 0.2234, "dayHigh": 0.242, "regularMarketPreviousClose": 0.22, "regularMarketOpen": 0.234, "regularMarketDayLow": 0.2234, "regularMarketDayHigh": 0.242, "payoutRatio": 0.0, "beta": 1.112, "forwardPE": -0.6215584, "volume": 202041, "regularMarketVolume": 202041, "averageVolume": 457273, "averageVolume10days": 389580, "averageDailyVolume10Day": 389580, "bid": 0.1908, "ask": 0.3438, "bidSize": 2, "askSize": 2, "marketCap": 6377246, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 1.3, "allTimeHigh": 236.0, "allTimeLow": 0.22, "fiftyDayAverage": 0.3072, "twoHundredDayAverage": 0.4508, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1133940, "profitMargins": 0.0, "floatShares": 23889958, "sharesOutstanding": 26649587, "sharesShort": 407422, "sharesShortPriorMonth": 419384, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0153, "heldPercentInsiders": 0.02243, "heldPercentInstitutions": 0.03937, "shortRatio": 1.12, "shortPercentOfFloat": 0.0153, "impliedSharesOutstanding": 26649587, "bookValue": 0.189, "priceToBook": 1.2661376, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -8051798, "trailingEps": -0.6, "forwardEps": -0.385, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": -0.144, "52WeekChange": -0.7962963, "SandP52WeekChange": 0.14561749, "quoteType": "EQUITY", "currentPrice": 0.2393, "targetHighPrice": 3.0, "targetLowPrice": 1.5, "targetMeanPrice": 2.16667, "targetMedianPrice": 2.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 4606289, "totalCashPerShare": 0.192, "ebitda": -7854250, "totalDebt": 0, "quickRatio": 3.989, "currentRatio": 4.342, "returnOnAssets": -0.79357004, "returnOnEquity": -1.5501, "freeCashflow": -3887925, "operatingCashflow": -6621858, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ADIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 8.772727, "regularMarketPrice": 0.2393, "corporateActions": [], "postMarketTime": 1767399569, "regularMarketTime": 1767387600, "exchange": "NCM", "messageBoardId": "finmb_112638788", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532698200000, "postMarketChangePercent": 4.4713755, "postMarketPrice": 0.25, "postMarketChange": 0.010700002, "regularMarketChange": 0.019299999, "regularMarketDayRange": "0.2234 - 0.242", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 457273, "fiftyTwoWeekLowChange": 0.019299999, "fiftyTwoWeekLowChangePercent": 0.08772727, "fiftyTwoWeekRange": "0.22 - 1.3", "fiftyDayAverageChange": -0.06790002, "fiftyDayAverageChangePercent": -0.22102869, "twoHundredDayAverageChange": -0.2115, "twoHundredDayAverageChangePercent": -0.46916592, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "fiftyTwoWeekHighChange": -1.0606999, "fiftyTwoWeekHighChangePercent": -0.81592304, "fiftyTwoWeekChangePercent": -79.62963, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.6, "epsForward": -0.385, "epsCurrentYear": -0.5, "priceEpsCurrentYear": -0.4786, "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "displayName": "Adial Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-03"}]